Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year-Ended September 30, 2024
| PMYYX Fund | USD 46.42 0.01 0.02% |
Slightly above 55% of Putnam Multicap's investor base is interested to short. The analysis of overall sentiment of trading Putnam Multicap Core mutual fund suggests that many investors are impartial at this time. Putnam Multicap's investing sentiment can be driven by a variety of factors including economic data, Putnam Multicap's earnings reports, geopolitical events, and overall market trends.
Putnam |
Enanta Pharmaceuticals, Inc. , a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunol
Read at businesswire.com
 |
Putnam Multicap Fundamental Analysis
We analyze Putnam Multicap's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Putnam Multicap using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Putnam Multicap based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Position Weight
Cash Position Weight Comparative Analysis
Putnam Multicap is currently under evaluation in cash position weight among similar funds. Percentage of fund asset invested in cash equivalents or risk-free instruments. About 40% of all global funds carry cash on their balance sheet.
Putnam Multicap Core Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Putnam Multicap mutual fund to make a market-neutral strategy. Peer analysis of Putnam Multicap could also be used in its relative valuation, which is a method of valuing Putnam Multicap by comparing valuation metrics with similar companies.
Peers
Putnam Multicap Related Equities
| BGHDX | Baillie Gifford | 6.78 | ||||
| GGHYX | Invesco Global | 0.24 | ||||
| LYFAX | Alphacentric Lifesci | 0.22 | ||||
| THQ | Tekla Healthcare | 0.1 | ||||
| SHISX | Blackrock Health | 0.33 | ||||
| BHSRX | Blackrock Health | 0.33 | ||||
| ETCHX | Eventide Healthcare | 1.87 | ||||
| DLHIX | Delaware Healthcare | 11.90 |
Other Information on Investing in Putnam Mutual Fund
Putnam Multicap financial ratios help investors to determine whether Putnam Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Putnam with respect to the benefits of owning Putnam Multicap security.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |